/
/
/

Arvee Laboratories (India) Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Mar 2017
₹17 Cr₹11 Cr₹10 Cr₹3 Cr₹7 Cr₹6 Cr₹9 Cr₹13 Cr₹11 Cr₹6 Cr₹8 Cr₹9 Cr₹8 Cr₹13 Cr₹16 Cr₹23 Cr₹18 Cr₹13 Cr₹8 Cr₹11 Cr₹9 Cr₹9 Cr₹20 Cr₹10 Cr₹9 Cr₹8 Cr₹0
₹18 L₹15 L₹14 L₹23 L₹17 L₹21 L₹19 L₹16 L₹11 L₹21 L₹19 L₹9 L₹9 L₹6 L₹7 L₹6 L₹2 L₹21 L₹12 L₹7 L₹6 L₹29 L₹13 L₹11 L₹33 L₹10 L₹0
₹17 Cr₹11 Cr₹10 Cr₹4 Cr₹8 Cr₹7 Cr₹9 Cr₹13 Cr₹11 Cr₹6 Cr₹8 Cr₹9 Cr₹8 Cr₹13 Cr₹16 Cr₹23 Cr₹18 Cr₹13 Cr₹8 Cr₹11 Cr₹9 Cr₹9 Cr₹20 Cr₹10 Cr₹9 Cr₹8 Cr₹0
₹15 Cr₹10 Cr₹8 Cr₹4 Cr₹7 Cr₹6 Cr₹9 Cr₹11 Cr₹9 Cr₹6 Cr₹8 Cr₹9 Cr₹7 Cr₹12 Cr₹15 Cr₹20 Cr₹17 Cr₹12 Cr₹7 Cr₹10 Cr₹8 Cr₹8 Cr₹18 Cr₹9 Cr₹8 Cr₹8 Cr₹0
₹3 Cr₹1 Cr₹2 Cr₹36 L₹51 L₹43 L₹54 L₹2 Cr₹2 Cr₹1 Cr₹72 L₹78 L₹1 Cr₹1 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹0
₹7 L₹8 L₹7 L₹4 L₹4 L₹7 L₹5 L₹5 L₹8 L₹5 L₹5 L₹8 L₹7 L₹7 L₹9 L₹11 L₹11 L₹9 L₹9 L₹6 L₹12 L₹9 L₹11 L₹23 L₹9 L₹20 L₹0
₹2 Cr₹85 L₹1 Cr₹1 L₹17 L₹9 L₹21 L₹1 Cr₹1 Cr₹58 L₹32 L₹28 L₹65 L₹67 L₹1 Cr₹3 Cr₹2 Cr₹1 Cr₹67 L₹1 Cr₹71 L₹63 L₹2 Cr₹30 L₹67 L₹67 L₹0
₹2 Cr₹52 L₹2 Cr₹1 L₹17 L₹7 L₹16 L₹98 L₹94 L₹12 L₹24 L₹21 L₹49 L₹1 L₹92 L₹2 Cr₹1 Cr₹79 L₹1 Cr₹73 L₹53 L₹43 L₹2 Cr₹21 L₹50 L₹63 L₹0

Share Price Live Stats

Open (₹)210.15
Volume (₹)2,455.00
High (₹)216.90
Upper Circuit220.65
Low (₹)202.40
Lower Circuit199.65
Prev Close210.15
52W High (₹)290.78
Price216.50
52W Low (₹)129.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)231.59 Cr
Div. Yield (%)0.00
PE Ratio57.21
Debt to Equity0.03
Price to Book4.37
Book Value30.66
EPS (TTM)3.67
Face Value10.00
ROE (%)7.77

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SOLARINDSNSE
PIDILITINDNSE
SRFNSE
FLUOROCHEMNSE
NAVINFLUORNSE
GODREJINDNSE
DEEPAKNTRNSE
AETHERNSE
FINEORGNSE
AARTIINDNSE
ARVEENSE
LTP
1W Low
1W High
Market cap (₹)
19654+224 (1.15%)
18800
20880
1,75,629Cr
1510.9+88.9 (6.25%)
1400.20
1528.50
1,51,253Cr
2428.6+70 (2.97%)
2324.70
2428.60
71,142Cr
4463.9+183.7 (4.29%)
4175
4600
47,482Cr
8530+269.5 (3.26%)
8242
8745
43,119Cr
952.55+24.05 (2.59%)
896
980.50
31,376Cr
1520.6+44.2 (2.99%)
1504.70
1615
20,842Cr
1501.1-79.9 (-5.05%)
1490.30
1692.40
20,181Cr
5089-63 (-1.22%)
4919
5424
15,980Cr
439.15-2.9 (-0.66%)
425.05
459.80
15,562Cr
216.5+19.63 (9.97%)
199
217.04
232Cr

Key Highlights of Arvee Laboratories (India) Ltd’s P&L

In 2025-03-31, Arvee Laboratories (India) Ltd reported total revenue of ₹38.49Cr, compared with ₹30.35Cr in 2024-03-31, reflecting Arvee Laboratories (India) Ltd turnover.

Depreciation was ₹1.15Cr and finance costs were ₹24.83Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹2.87Cr in 2025-03-31 as compared to ₹1.83Cr in 2024-03-31.

Net Profit (PAT) was ₹2.15Cr in 2025-03-31 compared with ₹1.05Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.95 in 2025-03-31, compared with ₹0.95 in 2024-03-31.